FMR LLC has disclosed a 13% ownership stake in Odyssey Therapeutics, reflecting increased interest in the biological products sector.
| Name | Odyssey Therapeutics, Inc. |
|---|---|
| CIK | 0001882782 |
| Tickers | ODTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 863384382 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (212) 841-1000 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
FMR LLC has disclosed a 13% ownership stake in Odyssey Therapeutics, reflecting increased interest in the biological products sector.
Odyssey Therapeutics has filed its Q3 report, showcasing financial updates and collaborations in the biological products sector.
Odyssey Therapeutics, Inc. announces its financial results for Q3 2026, highlighting performance in the biological products sector.
Odyssey Therapeutics announces encouraging Phase 2a trial results for OD-001, enhancing its standing in the biological products industry.
72 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002807 | 005-95704 | 261526261 | 34 | 11594 | |||
| 2026-11-04 | 10-Q | 10-Q | 0001193125-26-446208 | 001-43270 | 261520039 | 34 | 12562555 | 1 | 1 | |
| 2026-11-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-446174 | 001-43270 | 261519968 | 34 | 221055 | 1 | 1 |
| 2026-10-20 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-425684 | 001-43270 | 261470488 | 34 | 21379229 | 1 | 1 |
| 2026-09-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-385477 | 001-43270 | 261366239 | 34 | 18919761 | 1 | 1 |
| 2026-08-06 | 10-Q | 10-Q | 0001193125-26-335822 | 001-43270 | 261245373 | 34 | 12475768 | 1 | 1 | |
| 2026-08-04 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-331512 | 001-43270 | 261235383 | 34 | 203754 | 1 | 1 |
| 2026-06-23 | 8-K | 8-K | 7.01,9.01 | 0001193125-26-278581 | 001-43270 | 261109044 | 34 | 18164499 | 1 | 1 |
| 2026-06-17 | 10-Q | 10-Q | 0001193125-26-274290 | 001-43270 | 261099182 | 34 | 11981517 | 1 | 1 | |
| 2026-06-17 | 8-K | 8-K | 2.02,9.01 | 0001193125-26-274291 | 001-43270 | 261099177 | 34 | 182849 | 1 | 1 |
| 2026-06-05 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-001419 | 005-95704 | 261067309 | 34 | 11413 | |||
| 2026-05-18 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002044377-26-000002 | 005-95704 | 26995603 | 34 | 15359 | |||
| 2026-05-18 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001072613-26-000468 | 005-95704 | 26995355 | 34 | 174737 | |||
| 2026-05-18 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001999371-26-011002 | 005-95704 | 26993186 | 34 | 22385 | |||
| 2026-05-15 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0001193125-26-226695 | 005-95704 | 26987287 | 34 | 36651 | |||
| 2026-05-15 | SCHEDULE 13D | xslSCHEDULE_13D_X02/primary_doc.xml | 0000950103-26-007273 | 005-95704 | 26985991 | 34 | 25496 | |||
| 2026-05-13 | 4 | FORM 4 | 0001999371-26-010652 | 23507 | ||||||
| 2026-05-12 | 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000417 | 9985 | ||||||
| 2026-05-12 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-26-000416 | 6651 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217656 | 74738 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217607 | 21832 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217600 | 4513 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217593 | 9570 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217592 | 5271 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217590 | 5299 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217589 | 4620 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217588 | 5281 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217587 | 5498 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217586 | 5244 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217585 | 11672 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217584 | 24065 | ||||||
| 2026-05-11 | 4 | 4 | 0001193125-26-217583 | 5492 | ||||||
| 2026-05-11 | 8-K | 8-K | 1.01,3.02,5.03,9.01 | 0001193125-26-216899 | 001-43270 | 26963676 | 34 | 414901 | 1 | 1 |
| 2026-05-11 | S-8 | S-8 | 0001193125-26-215197 | 333-295741 | 26960334 | 33 | 370951 | 1 | 1 | |
| 2026-05-08 | 424B4 | 424B4 | 0001193125-26-214819 | 333-295141 | 26959243 | 33 | 71259814 | |||
| 2026-05-07 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-26-001538 | 333-295141 | 26955840 | 33 | 1726 | ||
| 2026-05-07 | 3 | 3 | 0001193125-26-212887 | 21118 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212881 | 25474 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212880 | 18539 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212866 | 17575 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212865 | 20696 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212860 | 31344 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212859 | 18842 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212857 | 19917 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212852 | 31120 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212851 | 169689 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212847 | 26813 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212842 | 27407 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212841 | 17809 | ||||||
| 2026-05-07 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001999371-26-010245 | 12989 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212840 | 21602 | ||||||
| 2026-05-07 | 3 | INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES | 0001999371-26-010243 | 3748 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212837 | 17408 | ||||||
| 2026-05-07 | 3 | 3 | 0001193125-26-212828 | 17241 | ||||||
| 2026-05-07 | S-1MEF | S-1MEF | 0001193125-26-212775 | 333-295677 | 26955639 | 33 | 284374 | 1 | 1 | |
| 2026-05-07 | CERT | ODTX_8A_Cert_1882782.pdf | 0001354457-26-000416 | 001-43270 | 26952525 | 34 | 564591 | |||
| 2026-05-05 | 8-A12B | 8-A12B | 0001193125-26-205798 | 001-43270 | 26941840 | 34 | 28051 | |||
| 2026-05-04 | S-1/A | S-1/A | 0001193125-26-202398 | 333-295141 | 26934514 | 33 | 73480446 | 1 | 1 | |
| 2026-04-17 | S-1 | S-1 | 0001193125-26-161514 | 333-295141 | 26871547 | 33 | 80566395 | 1 | 1 | |
| 2026-04-03 | DRS/A | filename1.htm | 0001193125-26-142305 | 377-09019 | 26838819 | 33 | 69366455 | |||
| 2026-03-16 | DRS/A | filename1.htm | 0001193125-26-108608 | 377-09019 | 26757884 | 33 | 93496704 | |||
| 2026-02-06 | DRS | filename1.htm | 0001193125-26-041396 | 377-09019 | 26608714 | 33 | 9931097 | |||
| 2025-12-04 | D | xslFormDX01/primary_doc.xml | 06b | 0001104659-25-118426 | 021-565797 | 251549127 | 33 | 15428 | ||
| 2025-06-09 | RW | RW | 0001193125-25-137861 | 333-284332 | 251034527 | NE | 9799 | |||
| 2025-01-17 | S-1 | S-1 | 0001193125-25-008362 | 333-284332 | 25538353 | 33 | 19714626 | |||
| 2024-12-05 | DRS/A | filename1.htm | 0000950123-24-012178 | 377-07486 | 241527795 | 33 | 15858530 | |||
| 2024-11-18 | DRS/A | filename1.htm | 0000950123-24-012003 | 377-07486 | 241469525 | 33 | 15306301 | |||
| 2024-10-07 | DRS | filename1.htm | 0000950123-24-009534 | 377-07486 | 241355978 | 33 | 11829102 | |||
| 2024-08-14 | D/A | xslFormDX01/primary_doc.xml | 06b | 0001882782-24-000001 | 021-499898 | 241205787 | 33 | 12484 | ||
| 2023-12-15 | D | xslFormDX01/primary_doc.xml | 06b | 0001882782-23-000001 | 021-499898 | 231490568 | 33 | 10745 | ||
| 2022-10-27 | D | xslFormDX01/primary_doc.xml | 06b | 0001882782-22-000002 | 021-462964 | 221335197 | 33 | 9607 | ||
| 2021-10-14 | D | xslFormDX01/primary_doc.xml | 06b | 0001882782-21-000001 | 021-417003 | 211323654 | 33 | 9216 |
One latest value per concept from companyfacts (167 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 48.07M | 2026-11-02 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| dei | EntityListingParValuePerShare | Entity Listing, Par Value Per Share | USD/shares | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| ffd | NetFeeAmt | NetFeeAmt | USD | 19,634.4 | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-215197 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 19,634.4 | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-215197 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 142.18M | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-215197 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-08 | S-8 | 2026-05-11 | 0001193125-26-215197 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-07 | S-1MEF | 2026-05-07 | 0001193125-26-212775 | |||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 8.26M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | -115,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 12.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 1.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 13.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -985,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.09B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 7.94M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 8.29M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | AreaOfLand | Area of Land | sqft | 45,632 | 2021-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | Assets | Assets | USD | 438.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 337.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 1.13M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 307.47M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 306.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | 12.15M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 179,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 80.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 84.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 39.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 500.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 48.07M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 47.94M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 5,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest | Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest | USD | -145.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ConvertiblePreferredStockSharesIssuedUponConversion | Convertible Preferred Stock, Shares Issued upon Conversion | shares | 24.60M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 | |
| us-gaap | DeferredRevenueAdditions | Deferred Revenue, Additions | USD | 99,000 | 2025-01-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | Depreciation | Depreciation | USD | 2.80M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 3.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -5.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -5.12 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 166,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 4.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 37,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | FinanceLeaseInterestPaymentOnLiability | Finance Lease, Interest Payment on Liability | USD | 37,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 117,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 1.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear | Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year | USD | 86,000 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-335822 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 1.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -602,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 29.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | Goodwill | Goodwill | USD | 14.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | GoodwillForeignCurrencyTranslationGainLoss | Goodwill, Foreign Currency Translation Gain (Loss) | USD | -208,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -144.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 251,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 104,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncreaseDecreaseInAccountsPayableTrade | Increase (Decrease) in Accounts Payable, Trade | USD | 338,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -3.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Other Accounts Payable and Accrued Liabilities | USD | -1.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncreaseDecreaseInOtherNoncurrentAssets | Increase (Decrease) in Other Noncurrent Assets | USD | 854,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 2.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | InterestIncomeOther | Interest Income, Other | USD | 8.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 42,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | InvestmentIncomeAmortizationOfDiscount | Investment Income, Amortization of Discount | USD | 225,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-335822 |
| us-gaap | LeaseCost | Lease, Cost | USD | 6.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.101 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | Liabilities | Liabilities | USD | 62.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 438.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 26.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | MarketableSecuritiesCurrent | Marketable Securities, Current | USD | 245.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | MarketableSecuritiesNoncurrent | Marketable Securities, Noncurrent | USD | 60.99M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | 1.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 289.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -133.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -117.08M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -144.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -144.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | 7.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | Segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 151.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -151.92M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 4.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OperatingLeaseImpairmentLoss | Operating Lease, Impairment Loss | USD | 5.40M | 2025-01-01 | 2025-03-31 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 300,000 | 2025-06-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 5.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 17.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 5.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 16.14M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 2.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 839,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 4.43M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -1.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax | USD | -9,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -1.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -449,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 143,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 246.49M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 838,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 50.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 11.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 288.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 113.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ProceedsFromSaleOfPropertyPlantAndEquipment | Proceeds from Sale of Property, Plant, and Equipment | USD | 302,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 1.39M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -144.11M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 18.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 4.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | RedeemableNoncontrollingInterestEquityPreferredCarryingAmount | Redeemable Noncontrolling Interest, Equity, Preferred, Carrying Amount | USD | 703.56M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 | |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 110.67M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | RestrictedCashNoncurrent | Restricted Cash, Noncurrent | USD | 3.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -712.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 278,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 278,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 |
| us-gaap | SaleOfStockConsiderationReceivedOnTransaction | Sale of Stock, Consideration Received on Transaction | USD | 100.00M | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 |
| us-gaap | SegmentReportingOtherItemAmount | SegmentReportingOtherItemAmount | USD | 23.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 16.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardAwardVestingRightsPercentage | Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage | pure | 0.25 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested | USD | 100,000 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 126,825 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 13.02 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 39,725 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 15.44 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.042 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 35.02M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 700,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | shares | 92,140 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 135,921 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 4.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 17.42 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-06 | 0001193125-26-335822 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price | USD/shares | 14.71 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 91.63M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 8.16M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 11.09 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number | shares | 2.19M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price | USD/shares | 6.29 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 4.74 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price | USD/shares | 24.14 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 11.92 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 17.98 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 375.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 293,265 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 703.63M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 152,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | SubleaseIncome | Sublease Income | USD | 243,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 413.59M | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-06-17 | 0001193125-26-274290 | |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 2.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 28.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 28.14M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-04 | 0001193125-26-446208 |